Detalles de la búsqueda
1.
Combination treatment of a novel CXCR3 antagonist ACT-777991 with an anti-CD3 antibody synergistically increases persistent remission in experimental models of type 1 diabetes.
Clin Exp Immunol
; 214(2): 131-143, 2023 12 12.
Artículo
en Inglés
| MEDLINE | ID: mdl-37458220
2.
ACT-1004-1239, a first-in-class CXCR7 antagonist with both immunomodulatory and promyelinating effects for the treatment of inflammatory demyelinating diseases.
FASEB J
; 35(3): e21431, 2021 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-33595155
3.
Pharmacological Characterization of Aprocitentan, a Dual Endothelin Receptor Antagonist, Alone and in Combination with Blockers of the Renin Angiotensin System, in Two Models of Experimental Hypertension.
J Pharmacol Exp Ther
; 368(3): 462-473, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30622171
4.
Cenerimod, a selective S1P1 receptor modulator, improves organ-specific disease outcomes in animal models of Sjögren's syndrome.
Arthritis Res Ther
; 23(1): 289, 2021 11 29.
Artículo
en Inglés
| MEDLINE | ID: mdl-34839819
5.
Preclinical to clinical translation of cenerimod, a novel S1P1 receptor modulator, in systemic lupus erythematosus.
RMD Open
; 6(2)2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32917831
Resultados
1 -
5
de 5
1
Próxima >
>>